✦ LIBER ✦

Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma

✍ Scribed by Keiji Shimada; Mitsutoshi Nakamura; Marco A. De Velasco; Motoyoshi Tanaka; Yukiteru Ouji; Makito Miyake; Kiyohide Fujimoto; Kazuya Hirao; Noboru Konishi

Book ID: 108586557
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 593 KB
Volume: 101
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2009.01379.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utility of CD138 (syndecan-1) in disting

Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas

✍ Anjali Saqi; Shine S. Yun; Gordon H. Yu; Diane Alexis; Robert N. Taub; Charles A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Role of human papillomavirus in the deve

Role of human papillomavirus in the development of urothelial carcinoma

✍ Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Ahmet Bilici; Di 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 243 KB

Role of FGFR3 in urothelial cell carcino

Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target

✍ Margaret A. Knowles 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 541 KB

Immunoexpression and prognostic role of

Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma

✍ CHING-HSIU YANG; WEN-CHUN HUNG; SHENG-LAN WANG; WAN-YI KANG; WAN-TZU CHEN; YA-CH 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

The prognostic value of intraepithelial

The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma

✍ KHALID AL-SHIBLI; SAMER AL-SAAD; SIGVE ANDERSEN; TOM DONNEM; ROY M. BREMNES; LIL 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 587 KB

Role of p53 in the responses of human ur

Role of p53 in the responses of human urothelial cells to genotoxic damage

✍ Christine P. Diggle; Eva Pitt; Patricia Harnden; Ludwik K. Trejdosiewicz; Jennif 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB

Loss of p53 function is a feature of many types of malignancy, including transitional-cell carcinoma (TCC), where it is associated with high-grade lesions and the development of muscle-invasive disease. Genotoxic agents used as part of the treatment strategy may contribute to tumour progression by i